The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological response-Reference-Cited by-同舟云学术

The nucleotide changes within HBV core promoter/precore during the first 12weeks of nucleos(t)ide treatment might be associated with a better virological response

Published:2017-04 Issue: Volume:49 Page:116-121
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Peng Yaqin,Li Yutang,Hou Jinlin,Sun Jian,Su Mingze,Li Yao,Xiang Kuanhui,Yan Ling,Zhuang Hui,Li Tong

Funder

Major Science and Technology Special Project of China Thirteenth and Twelfth Five-year Plans

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference30 articles.

1. Core promoter/pre-core mutations are associated with lamivudine-induced HBeAg loss in chronic hepatitis B with genotype C;Asahina;J. Hepatol.,2003

2. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy;Chen;J. Hepatol.,2006

3. Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy;Cho;Hepatology,2000

4. Hepatitis B virus variants;Chotiyaputta;Nat. Rev. Gastroenterol. Hepatol.,2009

5. Prevalence of HBV precore/core promoter variants in the United States;Chu;Hepatology,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure;Antiviral Research;2021-08